PharmaCielo Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	13	8	14	30	27	146
Market Cap Growth	77.49%	-39.83%	-53.82%	12.26%	-81.46%	-49.31%
Enterprise Value	31.7	8.17	18.59	32.94	38.56	148.86
Last Close Price	0.06	0.05	0.08	0.18	0.18	0.98
PS Ratio	7.62	-	4.04	19.75	5.11	75.21
PB Ratio	-0.87	-0.55	-1.87	-18.13	4.24	7.57
EV/Sales Ratio	18.10	-	5.34	21.36	7.26	76.53
Debt / Equity Ratio	-	0	-0.62	-1.52	1.84	0.42
Net Debt / Equity Ratio	-1.20	-1.20	-2.71	-10.86	1.92	0.14
Net Debt / EBITDA Ratio	-	-	-4.57	-1.42	-1.10	-0.12
Net Debt / FCF Ratio	-	-	-10.35	-3.53	-1.18	-0.13
Asset Turnover	-	0	0.17	0.07	0.17	0.05
Inventory Turnover	-	0	1.44	1.31	2.10	3.45
Quick Ratio	0.02	0.02	0.02	0.01	0.13	0.73
Current Ratio	0.15	0.15	0.11	0.16	0.58	1.14
Return on Equity (ROE)	-	0.00%	206.81%	-691.70%	-112.89%	-116.87%
Return on Assets (ROA)	-	0.00%	-28.13%	-60.24%	-41.60%	-62.60%
Return on Invested Capital (ROIC)	-	0.00%	-38.82%	-80.96%	-61.55%	-108.89%
Return on Capital Employed (ROCE)	-	0.00%	582.23%	-150.00%	-55.17%	-83.65%
Buyback Yield / Dilution	-9.40%	-6.98%	-9.77%	-6.03%	-3.67%	-29.41%
Total Shareholder Return	-9.40%	-6.98%	-9.77%	-6.03%	-3.67%	-29.41%